Investment bankers at UBS are understood to be hard at work scanning the globe for acquisition opportunities for listed agrochemicals business Nufarm, which is eager to embark on transformational deals worth potentially billions of dollars, writes Bridget Carter and Scott Murdoch on TheAustralian.com.au.
It is understood Nufarm has the firepower to embark on such deals and within its sights could be a whole raft of subsidiaries from mega-mergers between ChemChina and Syngenta, Dow and DuPont and Bayer and Monsanto.
UBS has worked with Nufarm before but is now thought to be mandated for Nufarm, which did not comment yesterday.
Sources say the European Commission wants strong competition between research and development companies on the Continent, and that this could prevent many from embarking on big deals, placing Nufarm in a more favourable position.
The Australian manufacturer of crop protection products has a market value of about $2.5 billion, with most of its revenue generated from herbicide products and the Latin American market.